Evidence map›Paper›PMID 42640348›Full record

ArticleImmunologic research2026

Multifocal HPV16-positive squamous cell carcinomas in CTLA-4 haploinsufficiency: expanding the spectrum of virus-associated malignancies.

Christian Arvei Moen, Kristin Greve-Isdahl Mohn, Alexander Marks, Thea E Hetland Falkenthal, Patrick Juliebø-Jones, Hans Jørgen Aarstad, Svein Erik Moe, Christian Beisland, Daniela Elena Costea, Elisabet Ognedal and 3 more

Abstract readCase Reports
In one paragraph

Article in Immunologic research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Christian Arvei MoenDepartment of Urology, Haukeland University Hospital, 5021, Bergen, Norway. christian.arvei.moen@helse-bergen.no.
Kristin Greve-Isdahl MohnDepartment of Clinical Medicine, Influenza Centre, University of Bergen, Bergen, Norway.
Alexander MarksDepartment of Clinical Medicine, University of Bergen, Bergen, Norway.
Thea E Hetland FalkenthalCancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway.
Patrick Juliebø-JonesDepartment of Urology, Haukeland University Hospital, 5021, Bergen, Norway.
Hans Jørgen AarstadDepartment of Clinical Medicine, University of Bergen, Bergen, Norway.
Svein Erik MoeDepartment of Otolaryngology, Head and Neck Surgery, Haukeland University Hospital, Bergen, Norway.
Christian BeislandDepartment of Urology, Haukeland University Hospital, 5021, Bergen, Norway.
Daniela Elena CosteaDepartment of Clinical Medicine, University of Bergen, Bergen, Norway.
Elisabet OgnedalDepartment of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
Eirik BratlandDepartment of Clinical Medicine, University of Bergen, Bergen, Norway.
Hildegunn Høberg VettiDepartment of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
Ellen BergetDepartment of Pathology, Haukeland University Hospital, Bergen, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cytotoxic T-lymphocyte associated protein 4 (CTLA-4) haploinsufficiency is an inborn error of immunity characterized by immune dysregulation, autoimmunity, lymphoproliferation, and an increased risk of malignancy. While susceptibility to oncogenic viral infections has been proposed, the relationship between CTLA-4 haploinsufficiency and human papillomavirus (HPV)-driven carcinogenesis remains poorly characterized. We describe a patient with CTLA-4 haploinsufficiency who developed multiple HPV-associated malignancies. Clinical, pathological, virological, and genetic data were reviewed. Germline genetic testing was performed using whole-exome sequencing, and HPV DNA analysis was conducted on available tumor specimens. A man with a history of alopecia totalis and autoimmune thyroiditis developed five distinct malignancies by the age of 50 years, including Epstein-Barr virus (EBV)-associated gastric Hodgkin lymphoma, cutaneous squamous cell carcinoma (SCC), and three independent HPV16-positive SCCs involving the oral cavity, anus, and penis. Germline testing identified CTLA-4 haploinsufficiency caused by a likely pathogenic CTLA4 variant, c.406C > T (p.Pro136Ser). No additional germline variants associated with hereditary cancer predisposition were detected. HPV DNA analysis demonstrated HPV16 positivity in all three mucosal SCCs. This case expands the spectrum of malignancies associated with CTLA-4 haploinsufficiency and suggests that persistent high-risk HPV infection may represent an underrecognized complication of this disorder. The occurrence of three independent HPV16-positive SCCs raises the possibility that CTLA-4 deficiency predisposes to HPV-driven carcinogenesis and supports further investigation of HPV surveillance and cancer prevention strategies in affected individuals.

Indexed as

Carcinoma, Squamous CellCTLA-4 AntigenHuman papillomavirus 16Papillomavirus InfectionsGenetic Predisposition to DiseaseGerm-Line MutationHaploinsufficiencyHumansMaleMiddle AgedCTLA-4 AntigenCTLA4 protein, humanAutoimmunityCTLA4 variantHuman papillomavirusNext-generation sequencingPrimary immunodeficiencySquamous cell carcinoma

Identifiers

PMID42640348
PMCPMC13506675

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.